Kleber F X, Sabin G V, Thyroff-Friesinger U, Cabell B, Glogar D
Krankenhaus München-Schwabing, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität, München, FRG.
Cardiology. 1992;81(2-3):121-4. doi: 10.1159/000175786.
Ibopamine is an active dopamine analogue leading to improved renal perfusion and afterload reduction in heart failure. This report describes casuistic experiences in patients with severe heart failure awaiting heart transplantation. All patients could be stabilized, intravenous catecholamines be discontinued, and diuretics be reduced. Six of seven patients could be successfully transplanted. No major side effects were noted. Thus ibopamine can be a suitable adjunct for patients with endstage heart failure.
异波帕明是一种活性多巴胺类似物，可改善心力衰竭患者的肾灌注并降低后负荷。本报告描述了等待心脏移植的严重心力衰竭患者的个案经验。所有患者病情均可稳定，可停用静脉注射儿茶酚胺，并减少利尿剂用量。7例患者中有6例成功接受了移植。未观察到重大副作用。因此，异波帕明可以作为终末期心力衰竭患者的一种合适辅助药物。
